NasdaqGM - Delayed Quote USD
Klotho Neurosciences, Inc. (KLTO)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 7:58 PM EDT
Breakdown
12/31/2022
12/31/2021
Total Assets
2,539.4490
1,041.5030
Total Liabilities Net Minority Interest
1,360.2740
15.1350
Total Equity Gross Minority Interest
1,179.1750
1,026.3680
Total Capitalization
1,179.1750
1,026.3680
Preferred Stock Equity
0.5050
0.5050
Common Stock Equity
1,178.6700
1,025.8630
Net Tangible Assets
-1,030.7350
289.3850
Working Capital
-1,030.7350
289.3850
Invested Capital
2,526.1880
1,025.8630
Tangible Book Value
-1,031.2400
288.8800
Total Debt
1,347.5180
--
Net Debt
1,271.6460
--
Share Issued
15,130.3930
15,130.3930
Ordinary Shares Number
15,130.3930
15,130.3930
12/31/2021 - 4/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTBL Notable Labs, Ltd.
0.3428
+10.58%
LIPO Lipella Pharmaceuticals Inc.
0.4896
-0.99%
WINT Windtree Therapeutics, Inc.
1.0700
+17.16%
CHRO Chromocell Therapeutics Corporation
0.7299
+4.95%
GRI GRI Bio, Inc.
1.3200
+127.59%
SLRX Salarius Pharmaceuticals, Inc.
1.8200
-9.45%
XRTX XORTX Therapeutics Inc.
1.7100
-9.04%
NKGN NKGen Biotech, Inc.
0.4512
+12.86%
HOTH Hoth Therapeutics, Inc.
0.8800
-5.22%
IVA Inventiva S.A.
2.7300
+3.80%